18.28
-1.04(-5.38%)
Currency In USD
| Previous Close | 19.32 |
| Open | 20.46 |
| Day High | 20.56 |
| Day Low | 16.06 |
| 52-Week High | 20.77 |
| 52-Week Low | 4.64 |
| Volume | 2.05M |
| Average Volume | 160,201 |
| Market Cap | 224.03M |
| PE | -3.84 |
| EPS | -4.76 |
| Moving Average 50 Days | 11.6 |
| Moving Average 200 Days | 9.02 |
| Change | -1.04 |
If you invested $1000 in Corbus Pharmaceuticals Holdings, Inc. (CRBP) 10 years ago, it would be worth $320.7 as of October 20, 2025 at a share price of $18.28. Whereas If you bought $1000 worth of Corbus Pharmaceuticals Holdings, Inc. (CRBP) shares 5 years ago, it would be worth $621.77 as of October 20, 2025 at a share price of $18.28.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25
GlobeNewswire Inc.
Oct 18, 2025 7:00 AM GMT
3.6 mg/kg dose generated ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in mUCCRB-701 continues to demonstrate a favorable safety and tolerability profileRegistrational studies planned to start in mid-2026Company to host an HNSCC KOL event
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025
GlobeNewswire Inc.
Oct 14, 2025 12:00 PM GMT
Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmace
Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium
GlobeNewswire Inc.
Oct 07, 2025 12:00 PM GMT
NORWOOD, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage oncology and obesity company, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of C